vimarsana.com
Home
Live Updates
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript : vimarsana.com
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
TEVA earnings call for the period ending December 31, 2023.
Related Keywords
Iceland ,
United States ,
American ,
Stelara ,
Chris Schott ,
Balaji Prasad ,
Glen Santangelo Jefferies ,
Goldman Sachs ,
Madison Aron Jpmorgan ,
Balaji Prasad Barclays ,
America Merrill Lynch ,
David Amsellem ,
Glen Santangelo ,
Madison Aron ,
Oleksiy Soroka ,
Jason Gerberry ,
Richard Francis ,
David Amsellem Piper Sandler ,
Chris Schott Jpmorgan ,
Eric Hughes ,
Piper Sandler ,
Jason Gerberry Bank ,
Company Analyst ,
Barclays ,
Head Of Research ,
Bloomberg ,
Teva Pharmaceutical Industries ,
Pharmaceutical Industries ,
Eran Meir ,
Vice President ,
Motley Fool Stock Advisor ,
Stock Advisor ,
Eli Kalif ,
Chief Executive ,
North American ,
Healthy Future ,
Healthy People ,
Medical Officer ,
Chief Financial ,
North America ,
Yash Verma ,
North America Generics ,
Umer Raffat ,
Ulcerative Colitis ,
Nathan Rich ,
Senior Vice President ,
Business Performance ,
Chief Executive Officer ,
Executive Vice President ,
vimarsana.com © 2020. All Rights Reserved.